PRAX · Praxis Precision Medicines Inc
United States · RS rating 46 · As of 2026-11-03
| Price | 280.51 USD |
|---|---|
| 1-day change | +2.4% |
| RS rating (overall / 1M / 3M / 12M) | 46 / 53 / 42 / 81 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 26 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -4.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +27.4% |
| Market cap (USD) | $9.2B |